Arcadia Biosciences, Inc. engages in developing various crop productivity traits primarily in hemp, wheat, and soybean. The company's crop productivity traits are designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. Its products include GoodHemp, a commercial pipeline of non-GMO hemp seed varieties developed with modern crop innovation tools focused on genetic improvement of hemp; GoodWheat that redesigns wheat as a functional food adding value to the wheat supply chain by enabling a range of choices to meet consumer demands; and nutritional oils, such as gamma linolenic acid oils. The company has collaborations with Ardent Mills, LLC, Corteva AgriScience, and Arista Cereal Seeds Pty Ltd, and Bay State Milling Company. It operates in the United States, Argentina, Canada, Africa, Austria, and India. The company was incorporated in 2002 and is headquartered in Davis, California.
IPO Year: 2015
Exchange: NASDAQ
Website: arcadiabio.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/3/2022 | $7.00 → $6.00 | Buy | HC Wainwright & Co. |
4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)
4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)
4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)
4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)
4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)
4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)
4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)
4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)
4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)
4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)
– Total revenues increased 18% compared to Q3 2023 – – Zola® coconut water revenues grew 55% year over year – – Zola retail distribution expanded 68% vs. Q3 2023 – Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the third quarter and first nine months of 2024. "We are extremely pleased with our third-quarter 2024 results, which represent the progress we have made in transforming Arcadia's business as well as our ability to execute on the plan we laid out," said T.J. Schaefer, Arcadia's president and CEO. "Our total revenues increased 18 percent year over y
Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the third quarter of 2024 after market close on November 12, 2024. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss third-quarter results and key strategic achievements. Interested participants can join the conference call using the following options: An audio-only webcast of the conference call will be available, with a link posted in the Investors section of Arcadia's website. To join the live call, please register here, and a dia
-- Company closes $4M transaction with Corteva Agriscience -- -- Above Food Corp acquires GoodWheatTM brand -- -- Zola® coconut water sales increase 42% year over year -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the second quarter and first half of 2024. "The second quarter of 2024 was a significant turning point for Arcadia as we transform the business and chart our path to becoming cash flow positive," said T.J. Schaefer, president and CEO. "We monetized our wheat IP through two transactions: selling our resistant starch wheat trait to a wholly ow
Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the second quarter and first half of 2024 after market close on August 13, 2024. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss second-quarter results and key strategic achievements. Interested participants can join the conference call using the following options: An audio-only webcast of the conference call will be available, with a link posted in the Investors section of Arcadia's website. To join the live call, please regist
-- CEO Stan Jacot replaced by CFO Thomas J. Schaefer -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced that CEO Stan Jacot has left the company and been replaced by Thomas J. Schaefer, effective July 5, 2024. Schaefer was previously Arcadia's chief financial officer and will be replaced in that role by Mark Kawakami, Arcadia's current vice president of finance. "On behalf of Arcadia, I would like to thank Stan for his many contributions to the company," said Board of Directors Chairman Kevin Comcowich. "Under his leadership, Arcadia expanded the GoodWheat brand into three categories, sold the brand to
Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will host a call for analysts and investors after market close on May 22, 2024. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss recent strategic transactions. Interested participants can join the conference call using the following options: An audio-only webcast of the conference call will be available in the Investors section of Arcadia's website. To join the live call, please register here, and a dial-in number and unique PIN will be provided. Following completion of the cal
-- Transaction will accelerate scaling Arcadia's wheat IP with Above's vertically integrated, farm-to-fork supply chain -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, and Above Food Corp., an innovative food company leveraging its vertically integrated supply chain to deliver differentiated ingredients and consumer products, announced today that Above Food will purchase the GoodWheatTM brand of better-for-you wheat products from Arcadia for $4 million net. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240516202271/en/The GoodWheat brand includes pa
-- Company advances monetization of wheat technology with one-time payment of $4 million -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced today it has sold its non-GMO Resistant Starch (RS) Durum Wheat trait to longtime partner Corteva Agriscience. Under the terms of the agreement, Arcadia will receive $4 million and retain the right to continue using Resistant Starch Durum in its GoodWheat portfolio of wheat products, including pastas and mac & cheese. Corteva will acquire 24 RS Durum patents in 20 countries. Arcadia and Corteva began collaborating in 2017 when they signed an agreement to develop and
– Revenues increase sequentially and year-over-year – – Loss from continuing operations is at lowest level in 6 years – Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the first quarter of 2024. "Arcadia continued its positive trajectory in the first quarter of 2024," said Stan Jacot, president and CEO. "Revenue continues to grow, both sequentially and year-over-year, and we have transitioned the topline to high-quality revenue that generates gross profit across multiple sources. Operating expenses continued to decline at a double-digit pace versus last year
Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the first quarter of 2024 after market close on May 9, 2024. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss first-quarter results and key strategic achievements. Interested participants can join the conference call using the following numbers: U.S. Toll-Free Dial-In: +1 (888) 672-2415 International Dial-In: +1 (646) 307-1952 Passcode: 1615939 A live webcast of the conference call will be available on the Investors section of Arcad
10-Q - Arcadia Biosciences, Inc. (0001469443) (Filer)
8-K - Arcadia Biosciences, Inc. (0001469443) (Filer)
8-K/A - Arcadia Biosciences, Inc. (0001469443) (Filer)
10-Q - Arcadia Biosciences, Inc. (0001469443) (Filer)
8-K - Arcadia Biosciences, Inc. (0001469443) (Filer)
8-K - Arcadia Biosciences, Inc. (0001469443) (Filer)
8-K - Arcadia Biosciences, Inc. (0001469443) (Filer)
8-K - Arcadia Biosciences, Inc. (0001469443) (Filer)
8-K - Arcadia Biosciences, Inc. (0001469443) (Filer)
8-K - Arcadia Biosciences, Inc. (0001469443) (Filer)
- SEC Filing
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Arcadia Biosciences (NASDAQ:RKDA) with a Buy and lowers the price target from $10 to $6.
Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, and Above Food Corp., an innovative food company leveraging its vertically integrated supply chain to deliver differentiated ingredients and consumer products, announced today that Above Food will purchase the GoodWheatTM brand of better-for-you wheat products from Arcadia for $4 million net.
-- Company advances monetization of wheat technology with one-time payment of $4 million --Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced today it has sold its non-GMO Resistant Starch (RS) Durum Wheat trait to longtime partner Corteva Agriscience. Under the terms of the agreement, Arcadia will receive $4 million and retain the right to continue using Resistant Starch Durum in its GoodWheat portfolio of wheat products, including pastas and mac & cheese. Corteva will acquire 24 RS Durum patents in 20 countries.Arcadia and Corteva began collaborating in 2017 when they signed an agreement to develop and commer
Arcadia Biosciences (NASDAQ:RKDA) reported quarterly losses of $(1.78) per share which beat the analyst consensus estimate of $(2.52) by 29.37 percent. This is a 83.61 percent increase over losses of $(10.86) per share from the same period last year. The company reported quarterly sales of $1.255 million which beat the analyst consensus estimate of $1.194 million by 5.15 percent. This is a 1.87 percent increase over sales of $1.232 million the same period last year.
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Arcadia Biosciences (NASDAQ:RKDA) with a Buy and maintains $10 price target.
Arcadia Biosciences (NASDAQ:RKDA) reported its Q4 earnings results on Thursday, March 28, 2024 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Arcadia Biosciences beat estimated earnings by 19.0%, reporting an EPS of $-2.1 versus an estimate of $-2.58. Revenue was up $170 thousand from the same period last year. Past Earnings Performance Last quarter the company beat on EPS by $1.3 which was followed by a 3.0% drop in the share price the next day. Here's a look at Arcadia Biosciences's past performance: Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022 EPS Estimate -3.19 -4.80 -6.85 -6.80 EPS Actual -1.89 -2.64 -10.86 -6.31 Revenue Estimate 1.55M 1.82M 1.40M
HC Wainwright & Co. reiterated coverage of Arcadia Biosciences with a rating of Buy and set a new price target of $6.00 from $7.00 previously
HC Wainwright & Co. reiterated coverage of Arcadia Biosciences with a rating of Buy and set a new price target of $7.00 from $6.00 previously
Lake Street initiated coverage of Arcadia Biosciences with a rating of Buy and set a new price target of $4.50
HC Wainwright & Co. reiterated coverage of Arcadia Biosciences with a rating of Buy and set a new price target of $6.00 from $8.00 previously
4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)
4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)
4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)
SC 13G/A - Arcadia Biosciences, Inc. (0001469443) (Subject)
SC 13G - Arcadia Biosciences, Inc. (0001469443) (Subject)
SC 13G - Arcadia Biosciences, Inc. (0001469443) (Subject)
SC 13D/A - Arcadia Biosciences, Inc. (0001469443) (Subject)
SC 13G/A - Arcadia Biosciences, Inc. (0001469443) (Subject)
SC 13G/A - Arcadia Biosciences, Inc. (0001469443) (Subject)
SC 13G/A - Arcadia Biosciences, Inc. (0001469443) (Subject)
– Total revenues increased 18% compared to Q3 2023 – – Zola® coconut water revenues grew 55% year over year – – Zola retail distribution expanded 68% vs. Q3 2023 – Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the third quarter and first nine months of 2024. "We are extremely pleased with our third-quarter 2024 results, which represent the progress we have made in transforming Arcadia's business as well as our ability to execute on the plan we laid out," said T.J. Schaefer, Arcadia's president and CEO. "Our total revenues increased 18 percent year over y
Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the third quarter of 2024 after market close on November 12, 2024. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss third-quarter results and key strategic achievements. Interested participants can join the conference call using the following options: An audio-only webcast of the conference call will be available, with a link posted in the Investors section of Arcadia's website. To join the live call, please register here, and a dia
-- Company closes $4M transaction with Corteva Agriscience -- -- Above Food Corp acquires GoodWheatTM brand -- -- Zola® coconut water sales increase 42% year over year -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the second quarter and first half of 2024. "The second quarter of 2024 was a significant turning point for Arcadia as we transform the business and chart our path to becoming cash flow positive," said T.J. Schaefer, president and CEO. "We monetized our wheat IP through two transactions: selling our resistant starch wheat trait to a wholly ow
Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the second quarter and first half of 2024 after market close on August 13, 2024. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss second-quarter results and key strategic achievements. Interested participants can join the conference call using the following options: An audio-only webcast of the conference call will be available, with a link posted in the Investors section of Arcadia's website. To join the live call, please regist
Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will host a call for analysts and investors after market close on May 22, 2024. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss recent strategic transactions. Interested participants can join the conference call using the following options: An audio-only webcast of the conference call will be available in the Investors section of Arcadia's website. To join the live call, please register here, and a dial-in number and unique PIN will be provided. Following completion of the cal
– Revenues increase sequentially and year-over-year – – Loss from continuing operations is at lowest level in 6 years – Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the first quarter of 2024. "Arcadia continued its positive trajectory in the first quarter of 2024," said Stan Jacot, president and CEO. "Revenue continues to grow, both sequentially and year-over-year, and we have transitioned the topline to high-quality revenue that generates gross profit across multiple sources. Operating expenses continued to decline at a double-digit pace versus last year
Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the first quarter of 2024 after market close on May 9, 2024. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss first-quarter results and key strategic achievements. Interested participants can join the conference call using the following numbers: U.S. Toll-Free Dial-In: +1 (888) 672-2415 International Dial-In: +1 (646) 307-1952 Passcode: 1615939 A live webcast of the conference call will be available on the Investors section of Arcad
-- Second continuous year of gross profit growth -- -- Total SG&A expenses declined to the lowest levels since 2019 -- -- GoodWheatTM now in more than 3,500 stores with better-for-you pasta, pancake/waffle mixes and mac & cheese -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the fourth quarter and full year of 2023. "We are now at the halfway point of Project Greenfield, our three-year strategic plan to unlock the company's potential and provide a path to profitability, and the results of this focus are unmistakable," said Stan Jacot, president and CEO
Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the fourth quarter and full year of 2023 after market close on March 28, 2024. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss fourth-quarter and year-end results and key strategic achievements. Interested participants can join the conference call using the following options: An audio-only webcast of the conference call will be available, with a link posted in the Investors section of Arcadia's website. To join the live call, pl
-- Increased revenue from continuing operations 20% quarter over quarter -- -- Lowest SG&A expenses since 2019 -- -- GoodWheat™ expanding into third category with upcoming launch of Mac & Cheese -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the third quarter of 2023. "Arcadia continues to make excellent progress in executing Project Greenfield, our three-year strategic plan to unlock the company's potential and provide a path to profitability," said Stan Jacot, president and CEO. "GoodWheatTM pasta and pancake mixes and Zola® coconut water added more
-- CEO Stan Jacot replaced by CFO Thomas J. Schaefer -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced that CEO Stan Jacot has left the company and been replaced by Thomas J. Schaefer, effective July 5, 2024. Schaefer was previously Arcadia's chief financial officer and will be replaced in that role by Mark Kawakami, Arcadia's current vice president of finance. "On behalf of Arcadia, I would like to thank Stan for his many contributions to the company," said Board of Directors Chairman Kevin Comcowich. "Under his leadership, Arcadia expanded the GoodWheat brand into three categories, sold the brand to
DAVIS, Calif., Dec. 20, 2021 /PRNewswire/ -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced it has appointed Kevin Comcowich, current Chairman of the Arcadia Board of Directors, as interim chief executive officer, effective January 1, 2022, as the board of directors finalizes its search for a permanent CEO. As previously announced on September 7, 2021, the board of directors launched a national search for a new CEO as the company further expands into the consumer packaged goods (CPG) sector.
DAVIS, Calif., Nov. 22, 2021 /PRNewswire/ -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced it has named Brian Schaffer as senior vice president of sales, as the company continues to expand its consumer goods platforms. A seasoned sales and general management executive with deep CPG experience, Schaffer has a proven track record of building and leading world class sales organizations. He is tasked with driving the retail launch of Arcadia's GoodWheat brand, a company priority in 2022 as it w
DAVIS, Calif., Sept. 7, 2021 /PRNewswire/ -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced that it has launched a national search for a new Chief Executive Officer as the company further expands into the consumer packaged goods sector. CEO Matt Plavan will step down from the role once a successor is named, which is expected to occur by the end of the year. Plavan joined Arcadia in 2016 as Chief Financial Officer and has served as Chief Executive Officer since 2019, overseeing the company's
New York, March 04, 2021 (GLOBE NEWSWIRE) -- - Mawson Gold Limited (TSE:MAW) (OTCPINK:MWSNF) (FRA:MXR) encouraged by drill assays from South East Mount Isa project, Australia click here- Nextleaf Solutions Ltd (CSE:OILS) (OTCQB:OILFF) (FRA:L0MA) supplies its Rapid Emulsion Technology to cannabis-infused beverage manufacturer BevCanna Enterprises click here- NetCents Technology Inc (CSE:NC) (FRA:26N) (OTCQB:NTTCF) sees cryptocurrency transaction volumes top C$6.7M in February click here - FansUnite Entertainment Inc (CSE:FANS) (OTCQB:FUNFF) (FRA:4UY) subsidiaries apply for UK gambling licenses click here - Great Panther Mining Limited (TSE:GPR) (NYSEAMERICAN:GPL) (FRA: